A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2001
12/12/2001	EP0710122B1 Stabilized pharmaceutical peptide compositions
12/12/2001	EP0699075B1 MODIFIED FACTOR VII for inhibiting vascular restenosis and platelet deposition
12/12/2001	EP0666758B1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
12/12/2001	EP0662088B1 Inhibitor of collagen-stimulated platelet aggregation
12/12/2001	EP0626858B1 Use of protease inhibitors as antiviral agents
12/12/2001	EP0522091B1 Use of a mbp peptide for the preparation of a medicament for the treatment of multiple sclerosis
12/12/2001	CN1326511A Systemic viral/ligand gene delivery system and gene therapy
12/12/2001	CN1326509A MOraxella catarrhalis ABSB034 polypeptides and uses thereof
12/12/2001	CN1326467A Expression and export of angiostation and endostatin as immunofusins
12/12/2001	CN1326466A Method of producing functional immunoglubulin superfaminly protein
12/12/2001	CN1326465A Methods of conversion of interferson isoforms and products thereof
12/12/2001	CN1326361A Methods for detecting, preventing, and treating renal disorders by modulating, regulating and inhibiting connective tissue growth factor
12/12/2001	CN1326360A Use of enterobacterium protein OMPA for specific targeting towards antigen-presening cells
12/12/2001	CN1326357A Method of treating sickle cell disease and thalassemia
12/12/2001	CN1326356A Method of treating viral hemorrhagic fever
12/12/2001	CN1326355A Method of treating heparin-induced thrombocytopenia
12/12/2001	CN1326353A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
12/12/2001	CN1326351A Use of certain drugs for treating nerve root injury
12/12/2001	CN1326341A Dry powder for inhalation
12/12/2001	CN1326340A Pharmaceutical composition for treatment of acute disorders
12/12/2001	CN1326103A Metal die and manufacture thereof
12/12/2001	CN1326001A Polypeptide-dimethyl allyl diphosphate isomerase 11.22 and polynucleotide for coding it
12/12/2001	CN1326000A Polypeptide-human dihydroorotase 18 and polynucleotide for coding it
12/12/2001	CN1325999A Polypeptide-human dihydroorotase 10.23 and polynucleotide for coding it
12/12/2001	CN1325998A Polypeptide-human dihydroorotase 11 and polynucleotide for coding it
12/12/2001	CN1325997A Polypeptide-serine proteinase 11 and polynucleotide for coding it
12/12/2001	CN1325996A Polypeptide-serine proteinase 10 and polynucleotide for coding it
12/12/2001	CN1325995A Polypeptide-signal peptidase 28 and polynucleotide for coding it
12/12/2001	CN1325994A Polypeptide-serine proteinase 12 and polynucleotide for coding it
12/12/2001	CN1325993A Polypeptide-human ATP-dependent serine protein hydrolase 34 and polynucleotide for coding it
12/12/2001	CN1325991A Polypeptide-carboxylesterase 21 and polynucleotide for coding it
12/12/2001	CN1325990A Polypeptide-human phosphatidic acid phosphotase 2-12 and polynucleotide for coding it
12/12/2001	CN1325988A Polypeptide-human ubiquitin C-terminal hydrolase 13 and polynucleotide for coding it
12/12/2001	CN1325987A Polypeptide-enolpyruvate phosphate-dependent glycophosphate transferase 10 and polynucleotide for coding it
12/12/2001	CN1325986A Polypeptide-protein kinase 10 and polynucleotide for coding it
12/12/2001	CN1325985A Polypeptide-eukaryotic acetyltransferase 10 and polynucleotide for coding it
12/12/2001	CN1325984A Polypeptide-aspartate and ornithine transcarbamylase 11 and polynucleotide for coding it
12/12/2001	CN1325983A Polypeptide-human kinase 63 and polynucleotide for coding it
12/12/2001	CN1325982A Polypeptide-tyrosine-specific protein phosphotase 13 and polynucleotide for coding it
12/12/2001	CN1325981A Polypeptide-human EPH/ELK kinase (HEK) 12.43 and polynucleotide for coding it
12/12/2001	CN1325980A Polypeptide-human DPB methyltransferase 16 and polynucleotide for coding it
12/12/2001	CN1325979A Polypeptide-human dioxygenase 11 and polynucleotide for coding it
12/12/2001	CN1325978A Polypeptide-human NADH dehydrogenase sub-unit I-10 and polynucleotide for coding it
12/12/2001	CN1325977A Polypeptide-dihydrofolate reductase 22 and polynucleotide for coding it
12/12/2001	CN1325976A Polypeptide-aldehyde/ketone reductase 9.46 and polynucleotide for coding it
12/12/2001	CN1325975A Polypeptide-human NADH dehydrogenase subunit I-11 and polynucleotide for coding it
12/12/2001	CN1325974A Polypeptide-phosphoribosyl glycinamide synthetase 14 and polynucleotide for coding it
12/12/2001	CN1325973A Polypeptide-dihydropyrrole-5-carboxylate reductase 50 and polynucleotide for coding it
12/12/2001	CN1325972A Polypeptide-tyrosinase 10.34 and polynucleotide for coding it
12/12/2001	CN1325971A Polypeptide-dihydrofolate reductase 14 and polynucleotide for coding it
12/12/2001	CN1325970A Polypeptide-gammal-pyrroline-5-hydroxyreductase 12 and polynucleotide for coding it
12/12/2001	CN1325969A Polypeptide-tyrosinase 15 and polynucleotide for coding it
12/12/2001	CN1325968A Polypeptide-human peroxidase 23 and polynucleotide for coding it
12/12/2001	CN1325967A Polypeptide-human dehydrogenase 12 and polynucleotide for coding it
12/12/2001	CN1325966A Polypeptide-short-chain dehydrogenase 14 and polynucleotide for coding it
12/12/2001	CN1325965A Polypeptide-human dehydrogenase 37 and polynucleotide for coding it
12/12/2001	CN1325964A Polypeptide-human dioxygenase 10.89 and polynucleotide for coding it
12/12/2001	CN1325962A Polypeptide-phosphoribosyl glycinamide synthetase 11 and polynucleotide for coding it
12/12/2001	CN1325889A Polypeptide-human kazal-type inhibitor 11 and polynucleotide for coding it
12/12/2001	CN1325855A Polypeptide-dynein light median chain 20 and polynucleotide for coding it
12/12/2001	CN1325742A Polypeptide-tyrosine-specific protein phosphotase 13 and polynucleotide for coding it
12/12/2001	CN1325734A Process for preparing nm-phase calcium-phosphorus salt/collagen/high-molecular bone compounded porous material
12/12/2001	CN1325730A Application of alkaline fibroblast growth factor in preparing medicine to prevent and cure cerebral injury
12/12/2001	CN1325729A Application of R-phycoerythrin in preparing photosensitive medicine for phototherapy of tumor
12/12/2001	CN1076052C Nucleic acid sequences, carrier containing them, medical compositions and usage for treatment
12/12/2001	CN1075945C High-polymer encapsulated insulin microsome and its preparation method and use
12/11/2001	US6330472 Prophylactic and therapeutic treatment of the ductal epithelium for a mammary gland for cancer
12/11/2001	US6329517 Dermatomyositis-specific auto-antigen
12/11/2001	US6329509 Humanized antibody having specific amino acid sequences which binds to immunoglobulin e; diagnosis and treatment of allergies
12/11/2001	US6329508 Has variable region which binds to transferrin receptors on brain capillary endothelial cells; for drug or diagnostic agent delivery across blood-brain barrier
12/11/2001	US6329507 Dimer and multimer forms of single chain polypeptides
12/11/2001	US6329505 Amino acid sequence of polypeptide that is over-expressed in prostate tissue
12/11/2001	US6329503 Serpentine transmembrane antigens expressed in human cancers and uses thereof
12/11/2001	US6329501 Methods and compositions for targeting compounds to muscle
12/11/2001	US6329500 Amino acid sequence of peptide fragment of alpha-2-macroglobulin; for cytokine suppression; treatment of psoriasis, glomerulonephritis, atherosclerosis, and rhematoid arthritis; antiscarring/antifibrotic agents
12/11/2001	US6329499 Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein
12/11/2001	US6329498 Amino acid sequence; stable preparation for treatment of human immunodeficiency virus
12/11/2001	US6329497 Sandramycin analogs
12/11/2001	US6329425 Modulation of inflammation related to Columnar epithelia
12/11/2001	US6329417 Hepatitis C inhibitor tri-pepitides
12/11/2001	US6329394 Medical use for tachykinin antagonists
12/11/2001	US6329384 Endothelin antagonist and renin-angiotensin system inhibitor as a combined preparation
12/11/2001	US6329379 Oligopeptides for inhibiting hepatitis
12/11/2001	US6329365 Inhibitors of interleukin-1β converting enzyme
12/11/2001	US6329362 Modulation cell adhesion the compounds are able to inhibit the binding of alpha 4 integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.
12/11/2001	US6329352 Method and composition for treating sleep apnea
12/11/2001	US6329348 Method of inducing angiogenesis
12/11/2001	US6329344 Urea derivative of alkylene dioxyfuran ethers
12/11/2001	US6329341 Method of treating septic shock
12/11/2001	US6329340 Human Defensin DEF-X
12/11/2001	US6329339 Lactoferrin with glycyrrhizic acid as synergist
12/11/2001	US6329336 Glue and crosslinking agent using albumin
12/11/2001	US6329203 Antisense modulation of glioma-associated oncogene-1 expression
12/11/2001	US6329202 Antibodies directed against binding associated epitopes
12/11/2001	US6329199 A vector resistant to inactivation by human serum, produced in cells containing retroviral envelope protein sequence from feline endogenous virus, long terminal repeats sequences, signal and packaging sequences; for effective gene therapy
12/11/2001	US6329197 DNA encoding galanin GALR3 receptors and uses thereof
12/11/2001	US6329190 Targetting adenovirus with use of constrained peptide motifs
12/11/2001	US6329173 Method of intracellular binding target molecules
12/11/2001	US6329170 Nucleic acids and proteins of a rat ganglioside GM1-specific α1→2fucosyltransferase and uses thereof
12/11/2001	US6329168 A polynucleotide sequences encoding a polypetide; antibiotic screening for streptococcus pneumoniae

1 ... 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 ... 3163